M. Wouter Dercksen

Less aggressive treatment and worse overall survival in cancer patients with diabetes: A large population based analysis

Lonneke V. van de Poll‐Franse, Saskia Houterman, M.L.G. Janssen‐Heijnen et al. · International Journal of Cancer · 2007 · 316 citations

Prognosis of metastatic breast cancer subtypes: the hormone receptor/HER2-positive subtype is associated with the most favorable outcome

D.J.A. Lobbezoo, Roel J.W. van Kampen, Adri C. Voogd et al. · Breast Cancer Research and Treatment · 2013 · 239 citations

Breast Oncology, Medicine, Pathology +7

The genomic landscape of 85 advanced neuroendocrine neoplasms reveals subtype-heterogeneity and potential therapeutic targets

Job van Riet, Harmen J.G. van de Werken, Edwin Cuppen et al. · Nature Communications · 2021 · 117 citations · Full text

In real life, one-quarter of patients with hormone receptor-positive metastatic breast cancer receive chemotherapy as initial palliative therapy: a study of the Southeast Netherlands Breast Cancer Consortium

D.J.A. Lobbezoo, Roel J.W. van Kampen, Adri C. Voogd et al. · Annals of Oncology · 2015 · 78 citations · Full text

Palliative Care, Nursing, Initial Palliative Therapy +9

Primary Granulocyte Colony-Stimulating Factor Prophylaxis During the First Two Cycles Only or Throughout All Chemotherapy Cycles in Patients With Breast Cancer at Risk for Febrile Neutropenia

Maureen J.B. Aarts, Frank Peters, Caroline M.P.W. Mandigers et al. · Journal of Clinical Oncology · 2013 · 49 citations · Full text